The Lobbying Register, read carefully Epicycle

Returns

Every filed return on the register. Filter, then open any return on lobbying.ie to read it in full.

Clear all

Showing returns filed by Vertex Pharmaceuticals (Europe) Limited .

Filed returns
14
match these filters
Matching filed returns per period 0 0 0 0 1 Sep–Dec 2016: 1 filed returns Jan–Apr 2017: 1 filed returns May–Aug 2018: 1 filed returns Sep–Dec 2019: 1 filed returns May–Aug 2020: 1 filed returns Jan–Apr 2021: 1 filed returns May–Aug 2021: 1 filed returns Sep–Dec 2021: 1 filed returns May–Aug 2022: 1 filed returns Sep–Dec 2022: 1 filed returns Jan–Apr 2023: 1 filed returns May–Aug 2023: 1 filed returns Jan–Apr 2024: 1 filed returns May–Aug 2025: 1 filed returns 2017 2021 2023 2024
Filed returns per four-month period Click a column to list its returns.
PeriodRegistrantPolicy areaSubject, as filedOfficials namedLink
May–Aug 2025 Vertex Pharmaceuticals (Europe) Limited Health Meeting to discuss cystic fibrosis in Ireland and access to medicines for CF (Public policy or programme) 19 On lobbying.ie
Jan–Apr 2024 Vertex Pharmaceuticals (Europe) Limited Health Access to cystic fibrosis treatments in Ireland (Public policy or programme) 8 On lobbying.ie
May–Aug 2023 Vertex Pharmaceuticals (Europe) Limited Health Meeting to discuss access to cystic fibrosis medicines in Ireland (Public policy or programme) 10 On lobbying.ie
Jan–Apr 2023 Vertex Pharmaceuticals (Europe) Limited Health Access to cystic fibrosis medicines in Ireland (Public policy or programme) 27 On lobbying.ie
Sep–Dec 2022 Vertex Pharmaceuticals (Europe) Limited Health Meeting to discuss access to cystic fibrosis medicines in Ireland (Public policy or programme) 25 On lobbying.ie
May–Aug 2022 Vertex Pharmaceuticals (Europe) Limited Health Meeting to discuss access to cystic fibrosis medicines in Ireland (Public policy or programme) 35 On lobbying.ie
Sep–Dec 2021 Vertex Pharmaceuticals (Europe) Limited Health Meeting to discuss the cystic fibrosis in Ireland and access to innovative medicines in treating this and other serious diseases (Public policy or programme) 3 On lobbying.ie
May–Aug 2021 Vertex Pharmaceuticals (Europe) Limited Health Meeting to discuss the cystic fibrosis in Ireland and access to innovative medicines in treating this and other serious diseases (Public policy or programme) 2 On lobbying.ie
Jan–Apr 2021 Vertex Pharmaceuticals (Europe) Limited Health Cystic Fibrosis landscape in Ireland (Matters involving public funds) 15 On lobbying.ie
May–Aug 2020 Vertex Pharmaceuticals (Europe) Limited Health National Plan for Rare Diseases (Public policy or programme) 7 On lobbying.ie
Sep–Dec 2019 Vertex Pharmaceuticals (Europe) Limited Health Cystic Fibrosis landscape in Ireland (Matters involving public funds) 18 On lobbying.ie
May–Aug 2018 Vertex Pharmaceuticals (Europe) Limited Health Discussion on national policies for Rare Diseases (Public policy or programme) 1 On lobbying.ie
Jan–Apr 2017 Vertex Pharmaceuticals (Europe) Limited Health HSE Reimbursement Policy (Public policy or programme) 14 On lobbying.ie
Sep–Dec 2016 Vertex Pharmaceuticals (Europe) Limited Health HSE Reimbursement Policy (Public policy or programme) 19 On lobbying.ie

Policy areas in these returns

Public policy areaFiled returnsShareRelative to the largest
Health 14 100.0%